• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[西班牙跨学科血管预防委员会关于欧洲心血管疾病预防最新指南的声明]

[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention].

作者信息

Brotons C, Camafort M, Del Mar Castellanos M, Clarà A, Cortés O, Diaz Rodriguez A, Elosua R, Gorostidi M, Hernández A M, Herranz M, Justo S, Lahoz C, Niño P, Pallarés-Carratalá V, Pedro-Botet J, Pérez Pérez A, Royo-Bordonada M A, Santamaria R, Tresserras R, Zamora A, Zuza I, Armario P

机构信息

Sociedad Española de Medicina de Familia y Comunitaria-semFYC, Barcelona, España.

Sociedad Española de Medicina Interna, Barcelona, España.

出版信息

Hipertens Riesgo Vasc. 2022 Apr-Jun;39(2):69-78. doi: 10.1016/j.hipert.2022.02.003. Epub 2022 Mar 21.

DOI:10.1016/j.hipert.2022.02.003
PMID:35331672
Abstract

Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. We present the Spanish adaptation of the 2021 European Guidelines on Cardiovascular Disease (CVD) prevention in clinical practice. The current guidelines besides the individual approach greatly emphasize on the importance of population level approaches to the prevention of cardiovascular diseases. Systematic global CVD risk assessment is recommended in individuals with any major vascular risk factor. Regarding LDL-Cholesterol, blood pressure, and glycemic control in patients with diabetes mellitus, goals and targets remain as recommended in previous guidelines. However, it is proposed a new, stepwise approach (Step 1 and 2) to treatment intensification as a tool to help physicians and patients pursue these targets in a way that fits patient profile. After Step 1, considering proceeding to the intensified goals of Step 2 is mandatory, and this intensification will be based on 10-year CVD risk, lifetime CVD risk and treatment benefit, comorbidities and patient preferences. The updated SCORE algorithm-SCORE2, SCORE-OP- is recommended in these guidelines, which estimates an individual's 10-year risk of fatal and non-fatal CVD events (myocardial infarction, stroke) in healthy men and women aged 40-89 years. Another new and important recommendation is the use of different categories of risk according different age groups (< 50, 50-69 ≥ 70 years). Different flow charts of CVD risk and risk factor treatment in apparently healthy persons, in patients with established atherosclerotic CVD, and in diabetic patients are recommended. Patients with chronic kidney disease are considered high risk or very high-risk patients according to the levels of glomerular filtration rate and albumin-to-creatinine ratio. New lifestyle recommendations adapted to the ones published by the Spanish Ministry of Health as well as recommendations focused on the management of lipids, blood pressure, diabetes and chronic renal failure are included.

摘要

西班牙跨学科血管预防委员会关于欧洲心血管疾病预防指南更新的声明。我们展示了2021年欧洲心血管疾病(CVD)临床预防指南的西班牙文改编版。当前指南除了关注个体方法外,还极大地强调了群体层面预防心血管疾病方法的重要性。建议对有任何主要血管危险因素的个体进行系统的全球CVD风险评估。对于糖尿病患者的低密度脂蛋白胆固醇、血压和血糖控制,目标仍与先前指南中的建议一致。然而,提出了一种新的逐步治疗强化方法(步骤1和步骤2),作为帮助医生和患者以适合患者情况的方式实现这些目标的工具。在步骤1之后,必须考虑是否进行步骤2的强化目标,这种强化将基于10年CVD风险、终生CVD风险和治疗获益、合并症以及患者偏好。这些指南推荐了更新后的SCORE算法——SCORE2、SCORE-OP,该算法可估计40至89岁健康男性和女性发生致命和非致命CVD事件(心肌梗死、中风)的10年风险。另一项新的重要建议是根据不同年龄组(<50岁、50 - 69岁、≥70岁)使用不同的风险类别。推荐了针对看似健康者、已确诊动脉粥样硬化性CVD患者以及糖尿病患者的不同CVD风险和风险因素治疗流程图。根据肾小球滤过率和白蛋白与肌酐比值水平,慢性肾脏病患者被视为高危或极高危患者。纳入了与西班牙卫生部发布的建议相适应的新的生活方式建议,以及侧重于血脂、血压、糖尿病和慢性肾衰竭管理的建议。

相似文献

1
[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention].[西班牙跨学科血管预防委员会关于欧洲心血管疾病预防最新指南的声明]
Hipertens Riesgo Vasc. 2022 Apr-Jun;39(2):69-78. doi: 10.1016/j.hipert.2022.02.003. Epub 2022 Mar 21.
2
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention.西班牙跨学科血管预防委员会关于欧洲心血管疾病预防指南更新的声明。
Nefrologia (Engl Ed). 2023 May-Jun;43(3):360-369. doi: 10.1016/j.nefroe.2023.08.001. Epub 2023 Aug 25.
3
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention.西班牙跨学科血管预防委员会关于更新的欧洲心血管疾病预防指南的声明。
Clin Investig Arterioscler. 2022 Jul-Aug;34(4):219-228. doi: 10.1016/j.arteri.2022.03.003.
4
[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention.].[西班牙跨学科血管预防委员会关于欧洲心血管疾病预防最新指南的声明。]
Rev Esp Salud Publica. 2022 Mar 1;96:e202203027.
5
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines.西班牙跨学科血管预防委员会关于更新的欧洲心血管预防指南的声明。
Clin Investig Arterioscler. 2021 Mar-Apr;33(2):85-107. doi: 10.1016/j.arteri.2020.11.004. Epub 2021 Jan 22.
6
[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines].西班牙跨学科血管预防委员会关于欧洲心血管病预防指南更新的声明
Hipertens Riesgo Vasc. 2021 Jan-Mar;38(1):21-43. doi: 10.1016/j.hipert.2020.07.004. Epub 2020 Oct 14.
7
[Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].[2016年欧洲临床实践心血管疾病预防指南的西班牙文改编版]
Hipertens Riesgo Vasc. 2017 Jan-Mar;34(1):24-40. doi: 10.1016/j.hipert.2016.11.006. Epub 2016 Dec 23.
8
[Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].《2016年欧洲临床实践心血管疾病预防指南》的西班牙文改编版
Gac Sanit. 2017 May-Jun;31(3):255-268. doi: 10.1016/j.gaceta.2016.12.007. Epub 2017 Mar 11.
9
[Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].[《2016年欧洲临床实践心血管疾病预防指南》的西班牙文改编版]
Semergen. 2017 May-Jun;43(4):295-311. doi: 10.1016/j.semerg.2016.11.012. Epub 2017 May 19.
10
Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice.《2016年欧洲临床实践心血管疾病预防指南》的西班牙语译本
Clin Investig Arterioscler. 2017 Mar-Apr;29(2):69-85. doi: 10.1016/j.arteri.2016.11.004. Epub 2017 Feb 4.

引用本文的文献

1
[Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].[心血管预防建议。PAPPS 2022主题更新。PAPPS工作组]
Aten Primaria. 2022 Oct;54 Suppl 1(Suppl 1):102444. doi: 10.1016/j.aprim.2022.102444.